The agency’s officials announced it gave the pill daraxonrasib approval more than six months ahead of a target date.
Groundbreaking pancreatic cancer drug approved by FDA
Recommended
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!